Levosimendan following corrective surgery in neonates with congenital heart disease

Trial Profile

Levosimendan following corrective surgery in neonates with congenital heart disease

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Aug 2012

At a glance

  • Drugs Levosimendan (Primary) ; Cardiotonics
  • Indications Congenital heart defects; Low cardiac output
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Aug 2012 New trial record
    • 01 Jul 2012 Results published in Intensive Care Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top